BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34983408)

  • 1. Stroke among highly active antiretroviral therapy-naive people living with the human immunodeficiency virus in China: a retrospective study of the characteristics, risk factors, and prognosis.
    Zhang L; Wang Y; Xu Q; Zhang W; Liang H; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
    BMC Infect Dis; 2022 Jan; 22(1):4. PubMed ID: 34983408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher Risks of Virologic Failure and All-Cause Deaths Among Older People Living with HIV in Chongqing, China.
    Wu G; Zhou C; Zhang X; Zhang W; Lu R; Ouyang L; Xing H; Shao Y; Ruan Y; Qian HZ
    AIDS Res Hum Retroviruses; 2019; 35(11-12):1095-1102. PubMed ID: 31544479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and risk factors in HAART naïve and HAART experienced HIV positive persons in south west Ethiopia: a comparative study.
    Gedefaw L; Yemane T; Sahlemariam Z; Yilma D
    PLoS One; 2013; 8(8):e72202. PubMed ID: 23977253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of immunological non-response on incidence of Non-AIDS events in people living with HIV: A retrospective multicenter cohort study in Taiwan.
    Wen CH; Lu PL; Lin CY; Lin YP; Chen TC; Chen YH; Kuo SH; Lo SH; Lin SY; Huang CH; Chang YT; Lee CY
    J Microbiol Immunol Infect; 2023 Oct; 56(5):977-987. PubMed ID: 37453914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
    He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
    PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal parasitosis in relation to CD4+T cells levels and anemia among HAART initiated and HAART naive pediatric HIV patients in a Model ART center in Addis Ababa, Ethiopia.
    Mengist HM; Taye B; Tsegaye A
    PLoS One; 2015; 10(2):e0117715. PubMed ID: 25658626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal Function Impairment and Associated Factors among HAART Naïve and Experienced Adult HIV Positive Individuals in Southwest Ethiopia: A Comparative Cross Sectional Study.
    Mekuria Y; Yilma D; Mekonnen Z; Kassa T; Gedefaw L
    PLoS One; 2016; 11(8):e0161180. PubMed ID: 27537338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excess mortality and associated factors among people living with HIV initiating highly active antiretroviral therapy in Luzhou, China 2006-2020.
    Niu D; Xiao T; Chen Y; Tang H; Chen F; Cai C; Qin Q; Zhao D; Jin Y; Wang S; Hou Y; Lu Z; Yang L; Liu H; Xie D; Zou H; Lyu F
    BMC Infect Dis; 2023 Mar; 23(1):186. PubMed ID: 36991355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis.
    Mabhida SE; Mchiza ZJ; Mokgalaboni K; Hanser S; Choshi J; Mokoena H; Ziqubu K; Masilela C; Nkambule BB; Ndwandwe DE; Kengne AP; Dludla PV
    BMC Infect Dis; 2024 Feb; 24(1):160. PubMed ID: 38308222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment-naïve people living with HIV aged 50 years or older in Beijing, China, 2010-2020: joinpoint regression model analysis of surveillance data.
    Wang D; Zhou M; Wang P; Zhang J; Mi Y; Cheng F; Liu J
    J Int AIDS Soc; 2023 Dec; 26(12):e26193. PubMed ID: 38054578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of serious non-AIDS-defining events among admitted cART-naive AIDS patients in China: An observational cohort study.
    Wang Y; Liang H; Zhang L; Zhang Z; Wu L; Ni L; Gao G; Yang D; Zhao H; Xiao J
    PLoS One; 2020; 15(12):e0243773. PubMed ID: 33351812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of anaemia and immunological markers among ghanaian HAART-naïve HIV-patients and those on HAART.
    Owiredu WK; Quaye L; Amidu N; Addai-Mensah O
    Afr Health Sci; 2011 Mar; 11(1):2-15. PubMed ID: 21572851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the effectiveness of highly active antiretroviral therapy in persons with human immunodeficiency virus using biomarker-based equivalence of disease progression.
    Jacobson LP; Li R; Phair J; Margolick JB; Rinaldo CR; Detels R; Muñoz A
    Am J Epidemiol; 2002 Apr; 155(8):760-70. PubMed ID: 11943695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological and virological discordance among people living with HIV on highly active antiretroviral therapy in Tigray, Northern Ethiopia.
    Hailu GG; Wasihun AG
    BMC Infect Dis; 2021 Jun; 21(1):561. PubMed ID: 34118891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and its predictors among highly active antiretroviral therapy naive hiv-infected individuals: data from prospective cohort study in Ukraine.
    Zhyvytsia D
    Georgian Med News; 2014; (232-233):69-74. PubMed ID: 25214276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological trends of severely immunosuppressed people living with HIV at time of starting antiretroviral treatment in China during 2005-2018.
    Hou Y; Liu J; Zhao Y; Wu Y; Ma Y; Zhao D; Dou Z; Liu Z; Shi M; Jiao Y; Huang H; Wu Z; Wang L; Han M; Wang FS
    J Infect; 2022 Mar; 84(3):400-409. PubMed ID: 34973280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus retinitis in patients with AIDS before and after introduction of HAART in China.
    Sun HY; Peng XY; Li D; Mao FF; You QS; Jonas JB
    Eur J Ophthalmol; 2014; 24(2):209-15. PubMed ID: 24030539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
    Jaén A; Esteve A; Miró JM; Tural C; Montoliu A; Ferrer E; Riera M; Segura F; Force L; Sued O; Vilaró J; Garcia I; Masabeu A; Altès J; Coltet B; Podzamczer D; Murillas J; Navarro G; Gatell JM; Casabona J;
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):212-20. PubMed ID: 18297762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicians' patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting.
    Allan B; Closson K; Collins AB; Kibel M; Pan S; Cui Z; McLinden T; Parashar S; Lima VD; Chia J; Yip B; Barrios R; Montaner JSG; Hogg RS
    BMJ Open; 2019 Mar; 9(3):e023957. PubMed ID: 30898806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.